May 2018

FIRST AUSTRALIAN TRIAL TO EXPLORE EFFECTS OF MEDICINAL CANNABIS ON INSOMNIA

Researchers at the University of Western Australia (UWA) are hoping the sedation effect brought on by medicinal cannabis could be an alternative to current drugs on the market and will be the first ones to test an oil containing cannabis on patients suffering with chronic sleeping issues.

UWA study lead, Professor Peter Eastwood said, ‘If it is as safe as people hope, if it works as well as people hope, then it could be a game changer, not just for insomnia, but for a bunch of health problems.’

Read the article here.

 

We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.

READ MORE >

We have successfully passed three consecutive TGO93 and TGO100 tests on our medicinal cannabis products since our first commercial harvest at the end of 2019.

READ MORE >

One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >